Name | Cetrorelix acetate |
---|---|
Synonyms |
N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide
N-Carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-N-[(2S)-3-(4-acetoxyphenyl)-2-{[3-(3-pyridinyl)-D-alanyl-O-acetyl-L-seryl]amino}propanoyl]-N-[N-acetyl-3-(2-naphthyl)-D-alanyl]-N-[(2R)-2-amino ; -3-(4-chlorophenyl)propanoyl]-D-alaninamide Cetrorenlin Acetate D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl- (2S)-N-[(2R)-1-Amino-1-oxopropan-2-yl]-1-[(2S,5S,8R,11S,14S,17R,20R,23R)-2-(3-carbamimidamidopropyl)-8-[3-(carbamoylamino)propyl]-20-(4-chlorobenzyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-5-isobutyl-23-(2-naphthylmethyl)-4,7,10,13,16,19,22,25-octaoxo-17-(pyridin-3-ylmethyl)-3,6,9,12,15,18,21,24-octaazahexacosan-1-oyl]pyrrolidine-2-carboxamide (non-preferred name) N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N5-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-L-tyrosyl-N-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide Cetrorelix D-Alaninamide, N-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-N-[N-acetyl-3-(2-naphthalenyl)-D-alanyl]-N-[(2S)-2-[[(2S)-3-(acetyloxy)-2-[[(2R)-2-amino-1-oxo-3-(3-pyridinyl)propyl]amino ]-1-oxopropyl]amino]-3-[4-(acetyloxy)phenyl]-1-oxopropyl]-N-[(2R)-2-amino-3-(4-chlorophenyl)-1-oxopropyl]- cetrorelixum [INN_la] |
Description | Cetrorelix diacetate (SB-075 diacetate) is a potent gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM[1]. |
---|---|
Related Catalog | |
Target |
IC50: 1.21 nM GnRH[1]. |
In Vitro | Cetrorelix diacetate inhibits growth of ES-2 cell line at 1000 ng/ml. Cetrorelix diacetate has comparable antiproliferative effects as GnRH-I agonists indicating that the dichotomy of GnRH-I agonists and antagonists might not apply to the GnRH-I system in cancer cells[2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 1768.4ºC at 760 mmHg |
Molecular Formula | C70H92ClN17O14 |
Molecular Weight | 1431.038 |
Flash Point | 1023.3ºC |
Exact Mass | 1429.669800 |
PSA | 518.21000 |
LogP | 2.69 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.668 |